TargetDrug is a research and development biopharmaceutical company focused on discovery and development of small molecule drugs targeting GPCRs (G protein coupled receptors). Based in Shanghai, TargetDrug is now a leading pioneer in GPCR-based drug discovery in China, dedicated to develop breakthrough treatments and innovative therapies to address unmet medical needs such as AIDS and cancer.